American Society of Maxillofacial Surgeons

3Sixty Academy Revolutionizing Dental Education with Live-Patient Program in Brazil

Retrieved on: 
Tuesday, October 31, 2023
Education, PMMA, LA, Anatomy, Amaral, Oral, American Association of Oral and Maxillofacial Surgeons, American Society of Maxillofacial Surgeons, Patient, Dentistry, Nursing, Medical device

ATLANTA, Oct. 31, 2023 /PRNewswire/ -- 3Sixty Academy, the educational arm of leading digital dentistry company 3Sixty, that aim to establish digital dentistry as the standard of care in both education and clinical practice, redefine dental education with the success of its first-ever live-patient course, the "Full-Arch Immersion Program: All-on-X Extravaganza."

Key Points: 
  • ATLANTA, Oct. 31, 2023 /PRNewswire/ -- 3Sixty Academy, the educational arm of leading digital dentistry company 3Sixty, that aim to establish digital dentistry as the standard of care in both education and clinical practice, redefine dental education with the success of its first-ever live-patient course, the "Full-Arch Immersion Program: All-on-X Extravaganza."
  • Held from August 11th to 13th, 2023, in Santos, Brazil, the program marked a monumental milestone for 3Sixty.
  • The program invited participating doctors to an intimate setting to gain hands-on experience that is truly invaluable.
  • 3Sixty Academy has just announced their return to Santos, Brazil, on March 28-31, 2024.

AcelRx Pharmaceuticals Announces Presentation of a Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA at Plastic Surgery The Meeting 2022

Retrieved on: 
Monday, October 31, 2022
European Medicines Agency, Hospital, Safety, Anxiety, Pain, PSF, Surgeon, Multimedia, Analgesic, Nitrous oxide, PCA, Rhinoplasty, SST, Government budget balance, Breast augmentation, SDA, Sufentanil, Merrell Dow Pharmaceuticals Inc. v. Thompson, American Society of Maxillofacial Surgeons, English, Precision, Ephedrine, Abdominoplasty, Patient, Female, Society, IV, ASPS, Naloxone, Adult, Hypoventilation, CA, Company, Plastic surgery, Tablet, American Society of Plastic Surgeons, Plasma, Breast reduction, Brachioplasty, Medication, Blepharoplasty, Anesthesia, Syringe, FACS, Vital signs, COVID-19, ASMS, Phenylephrine, Plastic, Nasdaq, Acute respiratory distress syndrome, Dentistry, Pharmaceutical industry, Louis Aguettant

HAYWARD, Calif., Oct. 31, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that an abstract, entitled, "Experience in Complex Outpatient Plastic Surgery Procedures Using Sufentanil Sublingual Tablets" was presented on Friday, October 28th by Jeffrey DeWeese, M.D., FACS, at Plastic Surgery The Meeting 2022, held October 27-30, in Boston, MA. The study, conducted in 324 patients undergoing complex plastic surgery procedures, found many positive benefits of using sufentanil sublingual tablets (SST), 30 mcg (brand name DSUVIA®), including the ability to perform complex, extensive cosmetic procedures without general anesthesia, allowing a rapid discharge time.

Key Points: 
  • This "awake" surgery analysis was a prospective, single-group cohort that were 95% female and ranged in age from 15 to 81 years.
  • Procedures included liposuction, breast augmentation, breast reduction, brachioplasty, facelift, rhinoplasty, and blepharoplasty, and most significantly, abdominoplasty, which is usually only performed under general anesthesia.
  • A sufentanil sublingual tablet (SST) 30 mcg (DSUVIA) was administered sublingually, followed by injection of local and/or tumescent anesthesia.
  • DSUVIA allows an option for patients not wanting to undergo general anesthesia for both short and lengthy plastic surgery procedures."

AcelRx Pharmaceuticals Announces Abstract Acceptance for Podium Presentation at Plastic Surgery: The Meeting 2022

Retrieved on: 
Thursday, August 11, 2022
Phenylephrine, Plastic, ASMS, Multimedia, Merrell Dow Pharmaceuticals Inc. v. Thompson, 2021 Essex County Council election, IV, Pain, SDA, European Medicines Agency, Hospital, Society, SST, Acute respiratory distress syndrome, Sufentanil, Plasma, Patient, Syringe, COVID-19, Company, American Society of Maxillofacial Surgeons, Ephedrine, Safety, American Society of Plastic Surgeons, PSF, English, Nasdaq, PCA, Analgesic, ASPS, Adult, Plastic surgery, Pharmaceutical industry, Louis Aguettant

The abstracts will be presented at the meeting and run from Thursday, October 27, 2022 at 1:30 pm until Sunday, October 30, 2022 at 4:30 pm ET.

Key Points: 
  • The abstracts will be presented at the meeting and run from Thursday, October 27, 2022 at 1:30 pm until Sunday, October 30, 2022 at 4:30 pm ET.
  • The time of the podium presentation is currently pending, but will be posted on the Investors/Events section of the AcelRx website once that information becomes available.
  • Plastic Surgery: The Meetingbrings together plastic surgeons from countries around the globe.
  • ASPS is the largest plastic surgery specialty organization in the world representing 94% of all board-certified plastic surgeons in the U.S. including more than 11,000 plastic surgeons worldwide.

JOMS study: More than 25 percent of children with cleft lip and/or palate travel over an hour for certified care

Retrieved on: 
Tuesday, August 10, 2021
Head, American Society of Maxillofacial Surgeons, Palate, Mouth, Patient, Insurance, Device file, OMS, Population, DMD, Education, Research, Plastic surgery, Oral, Anesthesia, Deformity, American Association, Analgesic, American Association of Oral and Maxillofacial Surgeons, Face, Connor, Division, Solution, CLP, Cleft lip and cleft palate, Surgeon, Association, MBA, Oral and maxillofacial surgery, Journal of Oral and Maxillofacial Surgery, Yale School of Medicine, Method, University of Connecticut, Birth, Anatomical pathology, Travel, University, Temporomandibular joint dysfunction, Section, Tooth, Department, AAOMS, Journal, Telehealth, Trauma center, Dentistry, Healthcare

Cleft lip and cleft palate (CLP) are some of the most common birth defects.

Key Points: 
  • Cleft lip and cleft palate (CLP) are some of the most common birth defects.
  • For the study, researchers examined an area within a one-hour radius of each of the 182 American Cleft Palate-Craniofacial Association-certified cleft centers.
  • Study results identified an estimated 103,776 U.S. children diagnosed with CLP, with more than 28,000 living over an hour from a certified cleft team.
  • "To overcome the challenges posed by geographic barriers to cleft care, teams should strive to implement creative solutions," researchers wrote.